DK144068C - Analogifremgangsmaade til fremstilling af 2-brom-6beta,9alfa-difluor-11beta,17alfa,21-trihydroxypregna-1,4-dien-3,20-dion-21-monoestere eller -17alfa,21-diestere - Google Patents
Analogifremgangsmaade til fremstilling af 2-brom-6beta,9alfa-difluor-11beta,17alfa,21-trihydroxypregna-1,4-dien-3,20-dion-21-monoestere eller -17alfa,21-diestereInfo
- Publication number
- DK144068C DK144068C DK61575A DK61575A DK144068C DK 144068 C DK144068 C DK 144068C DK 61575 A DK61575 A DK 61575A DK 61575 A DK61575 A DK 61575A DK 144068 C DK144068 C DK 144068C
- Authority
- DK
- Denmark
- Prior art keywords
- 17alfa
- 9alfa
- trihydroxypregna
- 6beta
- 11beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK280280A DK280280A (da) | 1974-02-27 | 1980-06-27 | Analogifremgangsmaade til fremstilling af 2-brom-6beta,9alfa-difluor-11beta,17alfa,21-trihydroxypregna-1,4-dien-3,20-dion-17-monoestere |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8928/74A GB1499822A (en) | 1974-02-27 | 1974-02-27 | 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones |
| GB892874 | 1974-02-27 | ||
| GB2998474 | 1974-07-05 | ||
| GB2998474 | 1974-07-05 | ||
| GB3294574 | 1974-07-25 | ||
| GB3294574 | 1974-07-25 | ||
| GB4998274 | 1974-11-19 | ||
| GB4998274 | 1974-11-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK61575A DK61575A (no) | 1975-10-27 |
| DK144068B DK144068B (da) | 1981-11-30 |
| DK144068C true DK144068C (da) | 1982-05-03 |
Family
ID=27447687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK61575A DK144068C (da) | 1974-02-27 | 1975-02-19 | Analogifremgangsmaade til fremstilling af 2-brom-6beta,9alfa-difluor-11beta,17alfa,21-trihydroxypregna-1,4-dien-3,20-dion-21-monoestere eller -17alfa,21-diestere |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5614677B2 (no) |
| AR (1) | AR218601A1 (no) |
| BE (1) | BE826030A (no) |
| CA (1) | CA1064476A (no) |
| CH (1) | CH608243A5 (no) |
| DE (3) | DE2508136C3 (no) |
| DK (1) | DK144068C (no) |
| ES (3) | ES435067A1 (no) |
| FI (1) | FI56188C (no) |
| FR (1) | FR2261776B1 (no) |
| GB (1) | GB1499822A (no) |
| IE (1) | IE42112B1 (no) |
| LU (1) | LU71908A1 (no) |
| NO (1) | NO144527C (no) |
| NZ (1) | NZ176716A (no) |
| RO (1) | RO78881A (no) |
| SE (1) | SE410736B (no) |
| YU (3) | YU108281A (no) |
-
1974
- 1974-02-27 GB GB8928/74A patent/GB1499822A/en not_active Expired
-
1975
- 1975-02-10 CA CA219,681A patent/CA1064476A/en not_active Expired
- 1975-02-14 FR FR7504616A patent/FR2261776B1/fr not_active Expired
- 1975-02-19 DK DK61575A patent/DK144068C/da not_active IP Right Cessation
- 1975-02-20 NZ NZ176716A patent/NZ176716A/xx unknown
- 1975-02-24 IE IE379/75A patent/IE42112B1/en unknown
- 1975-02-24 AR AR257732A patent/AR218601A1/es active
- 1975-02-25 FI FI750537A patent/FI56188C/fi not_active IP Right Cessation
- 1975-02-25 DE DE2508136A patent/DE2508136C3/de not_active Expired
- 1975-02-25 CH CH232575A patent/CH608243A5/xx not_active IP Right Cessation
- 1975-02-25 NO NO750633A patent/NO144527C/no unknown
- 1975-02-25 LU LU71908A patent/LU71908A1/xx unknown
- 1975-02-25 ES ES435067A patent/ES435067A1/es not_active Expired
- 1975-02-26 SE SE7502146A patent/SE410736B/xx unknown
- 1975-02-26 RO RO7581496A patent/RO78881A/ro unknown
- 1975-02-26 BE BE153787A patent/BE826030A/xx not_active IP Right Cessation
- 1975-02-26 JP JP2298075A patent/JPS5614677B2/ja not_active Expired
- 1975-07-25 DE DE2533377A patent/DE2533377C3/de not_active Expired
- 1975-07-25 DE DE2533323A patent/DE2533323C3/de not_active Expired
-
1977
- 1977-02-15 ES ES455933A patent/ES455933A1/es not_active Expired
- 1977-02-15 ES ES455934A patent/ES455934A1/es not_active Expired
-
1981
- 1981-04-27 YU YU01082/81A patent/YU108281A/xx unknown
- 1981-04-27 YU YU01084/81A patent/YU108481A/xx unknown
- 1981-04-27 YU YU01083/81A patent/YU108381A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK158786C (da) | Analogifremgangsmaade til fremstilling af 1alfa-hydroxyvitamin d3 eller diacetatet deraf | |
| DK138800B (da) | Analogifremgangsmåde til fremstilling af 4-aminoquinazolinderivater. | |
| DK138992B (da) | Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditonste heraf | |
| DK138501C (da) | Analogifremgangsmaade til fremstilling af 3alfa-hydroxy-d-homo-5alfa-pregnan-11,20-dioner | |
| DK150302C (da) | Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf | |
| DK144298C (da) | Fremgangsmaade til fremstilling af alkyl-tert-butylethere | |
| DK201675A (da) | Fremgangsmade til fremstilling af (1hydroximino-2,2-disubstitueret-5-indanyloxy(eller thio) )alkansyrer | |
| DK157138C (da) | Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner eller 6beta-acylamino-6alfa-alkoxypenicilliner | |
| DK490775A (da) | Fremgangsmade til fremstilling af eventuelt substituerede 1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-oner | |
| DK385475A (da) | Fremgangsmade til fremstilling af secoprostaglandiner | |
| DK137835B (da) | Analogifremgangsmåde til fremstilling af thienothiazinderivater. | |
| DK179675A (da) | Fremgangsmade til fremstilling af 6-amino-5-r3-2,4-diaminopyrimidin-3-oxider | |
| DK139846B (da) | Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider. | |
| DK136534C (da) | Analogifremgangsmade til fremstilling af d-homopregna-1,4-dien-3,20-dioner | |
| DK147854C (da) | Analogifremgangsmaade til fremstilling af n-(1-benzylpiperid-4-yl)-benzamider | |
| DK141849C (da) | Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere | |
| DK136729C (da) | Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner | |
| DK144033C (da) | Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf | |
| DK356375A (da) | Fremgangsmade til fremstilling af 2-thiol-4,5-diphenyloxazol-s-derivater | |
| DK153759C (da) | Analogifremgangsmaade til fremstilling af prostansyrederivater | |
| DK146718C (da) | Analogifremgangsmaade til fremstilling af benzobicyklononener | |
| DK143556C (da) | Analogifremgangsmaade til fremstilling af substituerede phenylisothiourinstoffer | |
| DK390975A (da) | Fremgangsmade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner | |
| DK543875A (da) | Fremgangsmade til fremstilling af hydroxyphenylacetonitriler | |
| DK156271C (da) | Analogifremgangsmaade til fremstilling af 1,2-5,6-dianhydro-3,4-di-o-acylgalactitolderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |